Wells Fargo’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-20,257
| Closed | -$494K | – | 6757 |
|
|
2017
Q4 | $494K | Buy |
20,257
+8,928
| +79% | +$172K | ﹤0.01% | 4407 |
|
|
2017
Q3 | $209K | Buy |
11,329
+4,846
| +75% | +$83.9K | ﹤0.01% | 4906 |
|
|
2017
Q2 | $107K | Sell |
6,483
-100
| -2% | -$1.39K | ﹤0.01% | 5140 |
|
|
2017
Q1 | $90K | Sell |
6,583
-372,952
| -98% | -$5.99M | ﹤0.01% | 5240 |
|
|
2016
Q4 | $7.2M | Sell |
379,535
-14,901
| -4% | -$286K | ﹤0.01% | 2105 |
|
|
2016
Q3 | $8.75M | Sell |
394,436
-102,229
| -21% | -$1.92M | ﹤0.01% | 1845 |
|
|
2016
Q2 | $9.07M | Sell |
496,665
-1,264
| -0.3% | -$21.8K | ﹤0.01% | 1912 |
|
|
2016
Q1 | $9.06M | Buy |
497,929
+33,379
| +7% | +$540K | ﹤0.01% | 1880 |
|
|
2015
Q4 | $7.83M | Buy |
464,550
+31,082
| +7% | +$528K | ﹤0.01% | 2013 |
|
|
2015
Q3 | $7.81M | Buy |
433,468
+183,632
| +74% | +$4.09M | ﹤0.01% | 1988 |
|
|
2015
Q2 | $6.46M | Buy |
249,836
+56
| +0% | +$1.42K | ﹤0.01% | 2223 |
|
|
2015
Q1 | $5.47M | Buy |
+249,780
| New | +$5.39M | ﹤0.01% | 2308 |
|
Wells Fargo's ENTL Position: Q1 2018 in Review
Wells Fargo sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 20,257 shares — an estimated $494K sold.
Wells Fargo first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $9.07M in Q2 2016. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.
- Wells Fargo reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
- Wells Fargo sold 20,257 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $494K.
- Wells Fargo first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
- Wells Fargo's Entellus Medical, Inc. Common Stock position peaked at $9.07M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.
Based on Wells Fargo's 13F filing for Q1 2018, filed 2 May 2018.